Home Blacklisting Icahn: How Some Drug Companies Keep Out Activists
 

Keywords :   


Blacklisting Icahn: How Some Drug Companies Keep Out Activists

2015-11-16 12:43:57| Biotech - Topix.net

When Concordia Healthcare Corp. agreed to issue a 14 percent stake to a private equity firm, the Canadian drug manufacturer tucked into the deal several layers of protection from shareholder activists. The agreement in October bars the buyout firm, Cinven, from transferring or reselling its Concordia shares to a list of almost 60 activist firms, including those run by Bill Ackman, Carl Icahn, and Dan Loeb, according to a regulatory filing.

Tags: out companies drug activists

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »